Malignant Neoplasm of Stomach Completed Phase 2 Trials for Capecitabine (DB01101)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01187212Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment EvaluationTreatment
NCT00780494Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric CarcinomaTreatment
NCT01748773A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction CancerTreatment
NCT02726399Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric CancerTreatment
NCT00215644Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric CancerTreatment
NCT01461057A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric CancerTreatment
NCT01364493A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric CancerTreatment
NCT00040859Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach CancerTreatment
NCT00054457Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionTreatment
NCT00278863Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized TrialTreatment
NCT00398398Study of XELOX With Cetuximab in Advanced Gastric CancerTreatment
NCT00436241A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.Treatment
NCT00454636A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.Treatment
NCT00477711A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric CancerTreatment
NCT00675194Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric CancerTreatment
NCT00718913Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric CancerTreatment
NCT00737438Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ AdenocarcinomaTreatment
NCT00733616Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General StatusTreatment
NCT00952497A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric CancerTreatment
NCT01130337A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric CancerTreatment
NCT01130805A Study of Pazopanib With CAPEOX in AGC PatientsTreatment
NCT01517009A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric CancerTreatment